Serum Level of Il-2 in Patients with Type 2 Diabetes Mellitus and Periodontopathy

Author:

Bunjaku V,Popovska M,Spasovski S,Spasovska-Gjorgovska A,Barani M,Mrasori Sh

Abstract

The purpose of this study was to investigate the influence of low-level laser therapy (LLLT) in patients with type 2 diabetes mellitus (T2DM) and chronic periodontopathy (ChP) on serum levels of IL-2. Methods and Results: A total of 80 patients aged 35-60 years were followed; all of them had T2DM diagnosed (HbA1C≤7.5%) with ChP, where clinical attachment loss (CAL) was ≥4mm on at least 50% of affected teeth. All participants are divided into two groups. Group A included 40 patients who underwent conservative (non-surgical) periodontal treatment supplemented with LLLT. Group B included 40 patients who underwent only conservative therapy. Patients used oral antidiabetic medications to control glycemia: Metformin (Alkaloid, Skopje S. Macedonia) 500 mg two times a day. LLLT (Laser HF® comfort, Hager. Werken, Duisburg, Germany) was applied (660 nm, 10 mW, 8 min/day) with contact to the gingiva for five consecutive days. Serum IL-2 was determined by ELISA in 3 time intervals: at the first examination, 6 weeks, and 3 months after treatment in both groups. In Group A and Group B, at the first examination, 6 weeks after therapy, and 3 months after treatment, the serum IL-2 was 17.20±0.54 pg/ml and 17.22±0.66 pg/ml, 17.12±0.63 pg/ml and 17.17±0.63 pg/ml, and 17.03±0.64 pg/ml and 16.98±0.65 pg/ml, respectively. In Group A, there was a significant difference between the serum IL-2 values in specified time points (first examination, 6 weeks, and 3 months after the therapy) (Friedman’s ANOVA: χ² (n=40, df=2) = 17.22 and P=0.0002). In Group B, between the serum IL-2 levels, there also was a significant difference in specified time points (Friedman’s ANOVA: χ² (n=40, df=2) = 42.33 and P=0.0000). The intergroup analysis, according to the temporal dynamics of the measurements, showed an evident difference between the two groups, but the serum IL-2 values in the two groups treated with and without LLLT were close, and no statistical significance was recorded between them. Conclusion: No significant differences were recorded in the serum IL-2 levels in T2DM patients with ChP non-surgically treated with and without the application of LLLT.

Publisher

International Medical Research and Development Corporation

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3